IMDX
Insight Molecular Diagnostics Inc.NASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$135.11M
P/E Ratio
—
EPS
$-1.65
Beta
1.53
52W High
$8.51
52W Low
$2.33
50-Day MA
$4.35
200-Day MA
$4.70
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Insight Molecular Diagnostics Inc.
OncoCyte Corporation is a precision diagnostics company in the United States and internationally. The company is headquartered in Irvine, California.
Fundamentals
| Revenue (TTM) | $4.05M |
| Gross Profit (TTM) | $2.31M |
| EBITDA | $-28.30M |
| Operating Margin | -874.00% |
| Return on Equity | -23603.00% |
| Return on Assets | -62.70% |
| Revenue/Share (TTM) | $0.13 |
| Book Value | $-1.10 |
| Price-to-Book | 196.27 |
| Price-to-Sales (TTM) | 33.32 |
| EV/Revenue | 31.32 |
| EV/EBITDA | -1.25 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -23.40% |
| Shares Outstanding | $32.17M |
| Float | $10.72M |
| % Insiders | 20.09% |
| % Institutions | 56.84% |
Historical Volatility
HV 10-Day
116.15%
HV 20-Day
125.85%
HV 30-Day
172.04%
HV 60-Day
143.26%
HV Rank
100.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($8.33 target)
1
Strong Buy1
Buy2
HoldData last updated: 4/29/2026